As of April 16, 2025, GH Research (GHRS) has a market cap of $0.56 billion USD. According to our data, GH Research is ranked No.5827 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.56 B |
28.43%
|
Dec 31, 2024 | $0.43 B |
20.69%
|
Dec 29, 2023 | $0.36 B |
-40.33%
|
Dec 30, 2022 | $0.60 B |
-58.34%
|
Dec 31, 2021 | $1.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() COMPASS Pathways
CMPS
|
$0.28 B |
-0.000 M
|
![]() UK
|
![]() Mind Medicine
MNMD
|
$0.42 B |
0.000 M
|
![]() USA
|
![]() Atai Life Sciences
ATAI
|
$0.28 B |
0.000 M
|
![]() Germany
|
![]() Cybin
CYBN
|
$0.16 B |
0.000 M
|
![]() Canada
|
![]() Seelos Therapeutics
SEEL
|
$0.21 M |
0.023 M
|
![]() USA
|
Market Cap | = | GHRS Stock Price | * | GHRS Shares Outstanding |
= | $8.99 | * | 62.03 M | |
= | $0.56 B |